Beruflich Dokumente
Kultur Dokumente
of interest to clinicians?
Due to the clinical and etiological heterogeneity of major depressive disorder, it has been difficult to elucidate its pathophysiology.
Current neurobiological theories with the most valid empirical foundation and the highest clinical relevance are reviewed with respect
to their strengths and weaknesses. The selected theories are based on studies investigating psychosocial stress and stress hormones,
neurotransmitters such as serotonin, norepinephrine, dopamine, glutamate and gamma-aminobutyric acid (GABA), neurocircuitry,
neurotrophic factors, and circadian rhythms. Because all theories of depression apply to only some types of depressed patients but not others,
and because depressive pathophysiology may vary considerably across the course of illness, the current extant knowledge argues against
a unified hypothesis of depression. As a consequence, antidepressant treatments, including psychological and biological approaches,
should be tailored for individual patients and disease states. Individual depression hypotheses based on neurobiological knowledge are
discussed in terms of their interest to both clinicians in daily practice and clinical researchers developing novel therapies.
Key words: Depression, pathophysiology, genetics, stress, serotonin, norepinephrine, dopamine, neuroimaging, glutamate, GABA
Major depressive disorder (MDD) is the major focus of the treatment of the Stress sensitivity in depression is
a common and costly disorder which is disorder. partly gender-specific. While men and
usually associated with severe and per- The above-mentioned studies consis- women are, in general, equally sensitive
sistent symptoms leading to important tently show that the influence of genetic to the depressogenic effects of stressful
social role impairment and increased factors is around 30-40% (4). Non-ge- life events, their responses vary depend-
mortality (1,2). It is one of the most im- netic factors, explaining the remaining ing upon the type of stressor. Specifically,
portant causes of disability worldwide 60-70% of the variance in susceptibility men are more likely to have depressive
(3). The high rate of inadequate treat- to MDD, are individual-specific environ- episodes following divorce, separation,
ment of the disorder remains a serious mental effects (including measurement and work difficulties, whereas women are
concern (1). error effects and gene-environment inter- more sensitive to events in their proximal
This review is aimed at summarizing actions). These effects are mostly adverse social network, such as difficulty getting
the solid evidence on the etiology and events in childhood and ongoing or re- along with an individual, serious illness,
pathophysiology of MDD that is likely cent stress due to interpersonal adversi- or death (10). These findings point to the
relevant for clinical psychiatry. Neuro- ties, including childhood sexual abuse, importance of gender-sensitive psycho-
biological findings are regarded as solid other lifetime trauma, low social support, social approaches in the prevention and
when they are consistent and conver- marital problems, and divorce (5,6). treatment of MDD.
gent, i.e., they have been confirmed by These results suggest that there is In contrast to the very solid evidence
several studies using the same method a huge potential in the prevention of from epidemiological studies on broad
and fit into results from studies using MDD by means of psychosocial in- risk factor domains, there is no solid
different methodological approaches. terventions (e.g., in schools, at work- evidence for specific genes and specific
place). In addition, these results mirror gene-by-environment interactions in the
the clinical practice of empirically vali- pathogenesis of MDD. Genome-wide
Genes and psychosocial stress dated psychotherapies to treat depres- association studies have indicated that
sion (7-9), including interpersonal, psy- many genes with small effects are in-
Family, twin, and adoption studies chodynamic and cognitive behavioral volved in complex diseases, increasing
provide very solid and consistent evi- psychotherapies and cognitive behav- the difficulty in identifying such genes
dence that MDD is a familial disorder ioural analysis system of psychotherapy, (11). While there has been progress in
and that this familiality is mostly or which all focus directly or indirectly on the search for risk genes for several com-
entirely due to genetic factors (4). This interpersonal difficulties and skills. This plex diseases despite this methodologi-
important finding suggests that parental does not exclude the fact that unidenti- cal problem (12), psychiatric conditions
social behavior and other familial en- fied non-genetic, non-psychosocial risk have turned out to be very resistant to
vironmental risk factors are not as im- factors may also play important roles robust gene identification. For example,
portant in the pathogenesis of MDD as in some patients (e.g., climatic change, based on a community-based prospec-
previously assumed and should not be medical conditions). tive study, it has been proposed that a
155
157
Genetic vulnerability Solid evidence from twin studies that 30-40% of MDD risk No specific MDD risk gene or gene-environment interaction
is genetic has been reliably identified
Altered HPA axis activity Plausible explanation for early and recent stress as MDD No consistent antidepressant effects of drugs targeting the
risk factor HPA axis
Deficiency of monoamines Almost every drug that inhibits monoamine reuptake has Monoamine deficiency is likely a secondary downstream
antidepressant properties effect of other, more primary abnormalities
Dysfunction of specific brain Stimulation of specific brain regions can produce Neuroimaging literature in MDD provides limited overlap
regions antidepressant effects of results
Neurotoxic and neurotrophic Plausible explanation of kindling and brain volume loss No evidence in humans for specific neurobiological
processes during the course of depressive illness mechanisms
Reduced GABAergic activity Converging evidence from magnetic resonance spectroscopy No consistent antidepressant effect of drugs targeting the
and post-mortem studies GABA system
Dysregulation of glutamate Potentially rapid and robust effects of drugs targeting the Questionable specificity, since glutamate is involved in
system glutamate system almost every brain activity
Impaired circadian rhythms Manipulation of circadian rhythms (e.g., sleep deprivation) No molecular understanding of the link between circadian
can have antidepressant efficacy rhythm disturbances and MDD
tigue are diagnostic criteria for MDD, sant effects of new therapeutics such as References
suggesting impaired sleep-wake regula- agomelatine directly relate to normaliza-
tion in depressed patients. In addition, tion of circadian rhythms (87). 1. Kessler RC, Berglund P, Demler O et al. The
epidemiology of major depressive disorder:
some depressive symptoms may show results from the National Comorbidity
diurnal variations (mood, psychomo- Survey Replication (NCS-R). JAMA 2003;
tor activity, accessibility of memories of ConclusionS 289:3095-105.
positive and negative experiences), and 2. Angst F, Stassen HH, Clayton PJ et al.
a subgroup of patients with MDD may The main strengths and weaknesses Mortality of patients with mood disorders:
follow-up over 34-38 years. J Affect Disord
have a circadian rhythm disorder (85). of the various neurobiological hypoth-
2002;68:167-81.
In healthy young subjects, moderate eses of depression are summarized in 3. Lopez AD, Mathers CD, Ezzati M et al.
changes in the timing of the sleep-wake Table 1. The many theories of depres- Global and regional burden of disease and
cycle had specific effects on subsequent sion and the relatively low response rate risk factors, 2001: systematic analysis of
mood (86). In depressed patients, ma- of all available antidepressant treatments population health data. Lancet 2006;367:
1747-57.
nipulations of circadian rhythms (light clearly argue against a unified hypoth-
4. Sullivan PF, Neale MC, Kendler KS. Ge-
therapy, sleep deprivation, phase ad- esis of depression and suggest that de- netic epidemiology of major depression:
vance treatment) can have antidepres- pression is a clinically and etiologically review and meta-analysis. Am J Psychiatry
sant efficacy. heterogeneous disorder. 2000;157:1552-62.
Based on these findings, circadian This encourages research on predic- 5. Kendler KS, Gardner CO, Prescott CA.
Toward a comprehensive developmental
abnormalities have been hypothesized tors of the response to therapeutic in-
model for major depression in men. Am J
to be etiologically associated with MDD terventions using biomarkers such as Psychiatry 2006;163:115-24.
(16). The association between phase ad- neuroimaging and neuroendocrine tests 6. Kendler KS, Gardner CO, Prescott CA.
vance of the sleep-wake cycle and phase in combination with genotyping for in- Toward a comprehensive developmental
advances in nocturnal cortisol secretion; ter-individual variability with respect to model for major depression in women. Am
shortened REM latency in some subjects stress sensitivity and antidepressant drug J Psychiatry 2002;159:1133-45.
7. Elkin I, Shea MT, Watkins JT et al. National
with MDD; and the effect of antidepres- action. Institute of Mental Health Treatment of De-
sants on circadian rhythms of behavior, The identification of reliable predic- pression Collaborative Research Program.
physiology, and endocrinology contrib- tors of therapeutic outcomes will allow General effectiveness of treatments. Arch
ute to the biological foundation of this for the development of personalized Gen Psychiatry 1989;46:971-82.
hypothesis (85,87,88). Despite of the medicine that has the potential to indi- 8. Leichsenring F, Rabung S, Leibing E. The
efficacy of short-term psychodynamic psy-
many promising findings, the molecular vidually tailor interventions and to open
chotherapy in specific psychiatric disorders:
and genetic underpinnings of this hy- up new pathways in the evaluation of a meta-analysis. Arch Gen Psychiatry 2004;
pothesis are largely unknown. It remains novel therapeutic approaches. 61:1208-16.
to be determined whether antidepres- 9. Thase ME, Rush AJ, Manber R et al. Differ-
159
161